Amgen, Immunex reach pricing settlement with Wisconsin
Pharma Compliance Alert, December 31, 2008
Amgen and Immunex agreed to pay a combined $1.7 million to settle charges they defrauded Wisconsin’s state Medicaid program by publishing false average wholesale prices for their products, according to a Wisconsin Department of Justice (DOJ) press release.
The DOJ filed suit against 36 pharmaceutical companies accusing them of reporting inflated average wholesale prices to pricing compendia for identified drugs. The Medicaid program utilized the compendia for the payment or reimbursement of pharmacists for Medicaid recipients and consequently paid substantially more than the actual cost of the drug.
The payment will go back to Medicaid. The companies also agreed to pay $300,000 to cover legal costs and fees. Amgen acquired Immunex in 2001.
The trial of another of the named defendants, Pfizer’s Pharmacia unit, is scheduled for February 2009.
Comments
0 comments on “Amgen, Immunex reach pricing settlement with Wisconsin ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
-
2012 OPPS Proposed Rule: Analyze the Impact and Manage the Changes
Expert speakers Jugna Shah, MPH, and Valerie A. Rinkle, MPA, return for this popular program. They review the proposed rule...
-
2012 OPPS Final Rule: Analyze the Impact and Manage the Changes
Expert speakers Jugna Shah, MPH, and Valerie A. Rinkle, MPA, return for this popular program. They review the final rule...
-
CPT 2012: Overview of Major Code Changes
This annual audio conference explains the CPT code changes for 2012. Our speakers present the latest information you need...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched